Comments

ABBV

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$189.99

NaN%

After Hours: 7:07 PM EDT

15 minutes delayed

(ABBV) Forecast

News Earnings Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

(ABBV) Stock Quotes, Forecast and News Summary

ABBV stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	- / -
Day Range	- - -
52 Wk Range	- - -
Market Cap	-
P/E Ratio	63.45
Dividend Yield	3.27%
Exchange
RSI	71
Short Interest	0.93%
Days to Cover	3.85

Recent News

Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations

Top pharmaceutical companies including Bristol Myers, Johnson & Johnson, AbbVie, and AstraZeneca foresee limited impact from the 2026 Medicare drug price cuts, easing initial industry concerns.

Vandana Singh

AbbVie Wins Analyst Confidence with Q2 Beat, Diverse Portfolio Fuels Long-Term Growth Expectations

AbbVie reports Q2 earnings with adjusted EPS of $2.65, surpassing expectations. Net revenues hit $14.46 billion, reflecting a 4.3% increase. Analysts maintain a positive outlook with increased price targets and confidence in future growth drivers.

Vandana Singh

Lockheed Martin To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Friday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Apr

May

Jun

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinv...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.